| No. | Project Title | PI Name | Co-Researcher | Project No | Project Start Date | Project End Date | Grant Type | Fund Source | Project Level | Project Allocation (RM) |
|
1 |
Isolating And Characterizing Exosonmal Micrornas In Tear Fluid In Diabetic Retinopathy | TENGKU AIN FATHLUN BINTI TENGKU KAMALDEN |
|
IF011-2020 | 4/1/2020 | 31/12/2023 | International Funding | Alcon Research Institute | International | 618,429.77 |
|
2 |
A Phase Ib Multicenter, Open-label Dose-escalation Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Durvalumab in Combination with Cisplatin, Carboplatin or Pemetrexed in First-line Treatment of Patients with Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human Epidermal Growth Factor Receptor 2 Overexpression (HER2+) (DESTINY-Lung03) | PROF HO |
|
D967YC00001 | 1/1/2022 | 31/12/2024 | Internatinal Funding | Astra Zeneca Industry Grant | International | 200,000 |
| UMRG / INTERNAL GRANTS | ||||
| NO. | PROJECT TITLE | SOURCES | RECIPIENTS | |
|
1 |
Physical Activity and Psychological status after Falls | UM | Nurliza Khaliddin | |
| EXTERNAL | ||||
| No. | PROJECT TITLE | SOURCES | RECIPIENTS | |
|
1 |
Retinopathy of Prematurity Outcomes in Malaysia | University of Sydney | Chaw May May | |
|
2 |
The Role Of Pancreatic β Cell-specific Exosomal Micrornas In Pathogenesis Of Diabetic Macular Edema | Bayer Fund | Tengku Ain Fathlun Tengku Kamalden | |
|
3 |
Isolating And Characterizing Exosomal Micrornas In Tear Fluid In Diabetic Retinopathy | Alcon Research Institute | Tengku Ain Fathlun, Tengku Kamalden, Nurliza Khaliddin, Nor Fadhilah Mohamad | |
| CLINICAL RESEARCH (UNDER CLINICAL INVESTIGATION CENTRE, CIC) | ||||
| No. | PROJECT TITLE | SOURCES | RECIPIENTS | |
|
1 |
RGH MD25 A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating The Efficacy, Safety, And Tolerability Of Cariprazine In A Dose-Reduction Paradigm In The Prevention Of Relapse In Bipolar I Disorder Patients Whose Current Episode Is Manic Or Depressive, With Or Without Mixed Features |
Allergan Malaysia Sdn. Bhd. | Amir Samsudin (Co-Researcher) | |
|
2 |
RGH MD24 A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating The Efficacy, Safety, And Tolerability Of Cariprazine In A Dose-Reduction Paradigm In The Prevention Of Relapse In Patients With Schizophrenia |
Allergan Malaysia Sdn. Bhd. | Amir Samsudin (Co-Researcher) | |
|
3 |
MK-3475-B15 A phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-B15/EV 304) |
Merck Sharp & Dohme (M Sdn Bhd) | Nor Fadhilah Mohamad (Co-Researcher) | |
|
4 |
CDRB436J12301 A Randomized, double-blind, Placebo-controlled Phase 3 study to Evaluate the Efficacy and Safety of Dafrafenib plus Trametinib in Previously Treated Patients with Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E mutation-positive Differentiated Thyroid Cancer |
Novartis Corporation (Malaysia) Sdn Bhd | Nor Fadhilah Mohamad (Co-Researcher) | |
| BKP SPECIAL | ||||
| NO. | PROJECT TITLE | SOURCES | RECIPIENT | GRANT NUMBER |
|
2 |
Ocular Disease And The Development Of A Self-Administered Tool For The Detection Of Ocular Involvement In Patients With Psoriasis And Psoriatic Arthritis |
UM Research Fund Assistance (BKP) |
Dr Sujaya Singh |
Bk035-2018 |
| TOTAL: RM 40,200.00 | ||||
| INTERNATIONAL GRANT | ||||
| NO. | PROJECT TITLE | SOURCES | RECIPIENT | |
|
1 |
The Role Of Pancreatic β Cell-specific Exosomal Micrornas In Pathogenesis Of Diabetic Macular Edema |
Global Ophthalmology Awards Program – BAYER |
A/P Dr Tengku Ain |
|
|
2 |
Isolating And Characterizing Exosonmal Micrornas In Tear Fluid In Diabetic Retinopathy |
Alcon Research Institute ARI Young Investigator Grant |
A/P Dr Tengku Ain |
|
| TOTAL: RM 533,818.38 | ||||
Last Update: 19/10/2023